Operating Lease, Right-of-Use Asset of PHIBRO ANIMAL HEALTH CORP from 30 Jun 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
PHIBRO ANIMAL HEALTH CORP quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Jun 2019 to 31 Dec 2025.
  • PHIBRO ANIMAL HEALTH CORP Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $39,416,000, a 5.5% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

PHIBRO ANIMAL HEALTH CORP Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $39,416,000 +$2,057,000 +5.5% 31 Dec 2025 10-Q 04 Feb 2026 2026 Q2
Q3 2025 $40,146,000 +$2,587,000 +6.9% 30 Sep 2025 10-Q 05 Nov 2025 2026 Q1
Q2 2025 $41,339,000 +$3,735,000 +9.9% 30 Jun 2025 10-Q 04 Feb 2026 2026 Q2
Q1 2025 $42,239,000 +$5,139,000 +14% 31 Mar 2025 10-Q 07 May 2025 2025 Q3
Q4 2024 $37,359,000 -$800,000 -2.1% 31 Dec 2024 10-Q 05 Feb 2025 2025 Q2
Q3 2024 $37,559,000 +$1,239,000 +3.4% 30 Sep 2024 10-Q 06 Nov 2024 2025 Q1
Q2 2024 $37,604,000 +$1,845,000 +5.2% 30 Jun 2024 10-K 27 Aug 2025 2025 FY
Q1 2024 $37,100,000 +$648,000 +1.8% 31 Mar 2024 10-Q 08 May 2024 2024 Q3
Q4 2023 $38,159,000 +$2,400,000 +6.7% 31 Dec 2023 10-Q 07 Feb 2024 2024 Q2
Q3 2023 $36,320,000 +$61,000 +0.17% 30 Sep 2023 10-Q 08 Nov 2023 2024 Q1
Q2 2023 $35,759,000 -$1,921,000 -5.1% 30 Jun 2023 10-K 28 Aug 2024 2024 FY
Q1 2023 $36,452,000 -$2,239,000 -5.8% 31 Mar 2023 10-Q 03 May 2023 2023 Q3
Q4 2022 $35,759,000 +$3,506,000 +11% 31 Dec 2022 10-Q 08 Feb 2023 2023 Q2
Q3 2022 $36,259,000 +$4,571,000 +14% 30 Sep 2022 10-Q 09 Nov 2022 2023 Q1
Q2 2022 $37,680,000 +$4,718,000 +14% 30 Jun 2022 10-K 30 Aug 2023 2023 FY
Q1 2022 $38,691,000 +$6,849,000 +22% 31 Mar 2022 10-Q 04 May 2022 2022 Q3
Q4 2021 $32,253,000 +$9,426,000 +41% 31 Dec 2021 10-Q 09 Feb 2022 2022 Q2
Q3 2021 $31,688,000 +$9,599,000 +43% 30 Sep 2021 10-Q 02 Nov 2021 2022 Q1
Q2 2021 $32,962,000 +$10,089,000 +44% 30 Jun 2021 10-K 24 Aug 2022 2022 FY
Q1 2021 $31,842,000 +$9,759,000 +44% 31 Mar 2021 10-Q 06 May 2021 2021 Q3
Q4 2020 $22,827,000 -$288,000 -1.2% 31 Dec 2020 10-Q 03 Feb 2021 2021 Q2
Q3 2020 $22,089,000 +$1,259,000 +6% 30 Sep 2020 10-Q 04 Nov 2020 2021 Q1
Q2 2020 $22,873,000 +$22,873,000 30 Jun 2020 10-K 25 Aug 2021 2021 FY
Q1 2020 $22,083,000 31 Mar 2020 10-Q 07 May 2020 2020 Q3
Q4 2019 $23,115,000 31 Dec 2019 10-Q 03 Feb 2020 2020 Q2
Q3 2019 $20,830,000 30 Sep 2019 10-Q 04 Nov 2019 2020 Q1
Q2 2019 $0 30 Jun 2019 10-K 26 Aug 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.